Company intelligence / Profile preview

NSVascular, Inc.

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Pre-clinical development of Thin-Film Nitinol (TFN)-covered stents showed 100% aneurysm occlusion rate in intracranial aneurysm models and potential for small vessel patency in PAD models.[1][3]

Therapeutic areas: CardiovascularNeurology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

University of California, Los Angeles (UCLA)

Beyond the preview

Go deeper on NSVascular, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NSVascular, Inc..

Explore the full profile